Trial Profile
A pharmacokinetic study of once-monthly aripiprazole extended-release injectable suspension (ERIS) in adult patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 27 Jul 2011 New trial record